Vanda Pharmaceuticals Inc.

NEW YORK STATE COMMON RETIREMENT FUND VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

11,376

Value ($000)

100

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	100	0.0%	11,376	12/31/2025
2025 Q3	11/3/2025	57	0.0%	11,376	9/30/2025
2025 Q2	10/8/2025	54	0.0%	11,376	6/30/2025
2025 Q1	10/8/2025	52	0.0%	11,376	3/31/2025
2024 Q4	10/8/2025	54	0.0%	11,376	12/31/2024
2024 Q3	10/8/2025	53	0.0%	11,376	9/30/2024
2024 Q2	10/8/2025	64	0.0%	11,376	6/30/2024
2024 Q1	10/8/2025	47	0.0%	11,327	3/31/2024
2023 Q4	10/8/2025	48	0.0%	11,392	12/31/2023
2023 Q3	10/8/2025	77	0.0%	17,805	9/30/2023
2023 Q2	10/8/2025	75	0.0%	11,335	6/30/2023
2023 Q1	10/8/2025	494	0.0%	72,693	3/31/2023
2022 Q4	10/8/2025	291	0.0%	39,376	12/31/2022
2022 Q3	11/8/2022	389	0.0%	39,399	9/30/2022
2022 Q2	8/4/2022	988	0.0%	90,628	6/30/2022
2022 Q1	7/1/2022	447	0.0%	39,493	3/31/2022
2021 Q4	2/2/2022	619	0.0%	39,460	12/31/2021
2021 Q3	11/2/2021	1,239	0.0%	72,266	9/30/2021
2021 Q2	8/2/2021	1,004	0.0%	46,653	6/30/2021
2021 Q1	5/11/2021	694	0.0%	46,200	3/31/2021
2020 Q4	2/8/2021	593	0.0%	45,100	12/31/2020
2020 Q3	11/5/2020	436	0.0%	45,100	9/30/2020
2020 Q2	8/7/2020	516	0.0%	45,100	6/30/2020
2020 Q1	5/6/2020	467	0.0%	45,100	3/31/2020
2019 Q4	2/5/2020	740	0.0%	45,100	12/31/2019